Literature DB >> 22638567

Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease.

Koji Fujita, Tatsuhiko Yuasa, Osamu Watanabe, Yukitoshi Takahashi, Shuji Hashiguchi, Katsuhito Adachi, Yuishin Izumi, Ryuji Kaji.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22638567     DOI： 10.1007/s00415-012-6554-y

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia.

Authors:  Hisanori Tomimitsu; Kimiyoshi Arimura; Tatsui Nagado; Osamu Watanabe; Reika Otsuka; Asutsugu Kurono; Yoshito Sonoda; Mitsuhiro Osame; Masaki Kameyama
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

2.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

Authors:  Meizan Lai; Maartje G M Huijbers; Eric Lancaster; Francesc Graus; Luis Bataller; Rita Balice-Gordon; John K Cowell; Josep Dalmau
Journal:  Lancet Neurol       Date:  2010-06-28       Impact factor: 44.182

3.  Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.

Authors:  Numthip Chitravas; Richard S Jung; Diane M Kofskey; Janis E Blevins; Pierluigi Gambetti; R John Leigh; Mark L Cohen
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

4.  Thorough work-up and new diagnostic criteria needed for CJD.

Authors:  David C Perry; Michael D Geschwind
Journal:  Nat Rev Neurol       Date:  2011-09-05       Impact factor: 42.937

5.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

6.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.

Authors:  Sarosh R Irani; Sian Alexander; Patrick Waters; Kleopas A Kleopa; Philippa Pettingill; Luigi Zuliani; Elior Peles; Camilla Buckley; Bethan Lang; Angela Vincent
Journal:  Brain       Date:  2010-07-27       Impact factor: 13.501
  6 in total
  8 in total

1.  Wait and see: a 5 year history of 'recurrent dementia'.

Authors:  Roberto D'Angelo; Rita Rinaldi; Piero Parchi; Fabio Cirignotta
Journal:  BMJ Case Rep       Date:  2014-11-19

2.  Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease.

Authors:  Adham Jammoul; Richard J Lederman; Jinny Tavee; Yuebing Li
Journal:  BMJ Case Rep       Date:  2014-06-05

Review 3.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 4.  Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.

Authors:  M T Montojo; M Petit-Pedrol; F Graus; J Dalmau
Journal:  Neurologia       Date:  2014-01-30       Impact factor: 3.109

5.  An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre.

Authors:  S Huda; S H Wong; P Pettingill; D O'Connell; A Vincent; M Steiger
Journal:  J Neurol       Date:  2014-11-27       Impact factor: 4.849

6.  Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.

Authors:  Oriol Grau-Rivera; Raquel Sánchez-Valle; Albert Saiz; José Luis Molinuevo; Reyes Bernabé; Elvira Munteis; Francesc Pujadas; Antoni Salvador; Júlia Saura; Antonio Ugarte; Maarten Titulaer; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

7.  Creutzfeldt-Jakob disease mimicking autoimmune encephalitis with CASPR2 antibodies.

Authors:  Frédéric Zuhorn; Almut Hübenthal; Andreas Rogalewski; Müjgan Dogan Onugoren; Markus Glatzel; Christian G Bien; Wolf-Rüdiger Schäbitz
Journal:  BMC Neurol       Date:  2014-11-30       Impact factor: 2.474

8.  Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.

Authors:  Ross W Paterson; Michael S Zandi; Richard Armstrong; Angela Vincent; Jonathan M Schott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-11       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.